McGirt MJ, Woodworth GF, Coon AL, et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: A risk assessment of 270 cases. J Neurosurg. 2005;102(5):897–901. doi:10.3171/jns.2005.102.5.0897
Hervey-Jumper SL, Berger MS. Maximizing safe resection of low- and high-grade glioma. J Neurooncol. 2016;130(2):269–282. doi:10.1007/s11060–016–2110–4
Aker FV, Hakan T, Karadereler S, Erkan M. Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: Comparison of results of biopsy and resected surgical specimens. Neuropathology. 2005;25(3):207–213. doi:10.1111/j.1440–1789.2005.00634.x
Mladenovsk M, Valkov I, Ovcharov M, Vasilev N, Duhlenski I. High Grade Glioma Surgery – Clinical Aspects and Prognosis. Folia Med (Plovdiv). 2021;63(1):35–41. doi:10.3897/folmed.63.e55255
Ganslandt O, Behari S, Gralla J, Fahlbusch R, Nimsky C. Neuronavigation : concept, techniques and applications. Neurol India. 2002;50(3):244–255. https://www.neurologyindia.com/article.asp?issn=0028–3886
Wang X, Li L, Luo P, et al. Neuronavigation-assisted trajectory planning for deep brain biopsy with susceptibility-weighted imaging. Acta Neurochir (Wien). 2016;158(7):1355–1362. doi:10.1007/s00701–016–2823–3
Enchev Y. Neuronavigation: Geneology, reality, and prospects. Neurosurg Focus. 2009;27(3):1–18. doi:10.3171/2009.6.FOCUS09109
Price R, Dorward NL. The advantages of frameless stereotactic biopsy over frame-based biopsy [3] (multiple letters). Br J Neurosurg. 2003;17(1):90–91. doi:10.3109/02688690309177985
Dhawan S, He Y, Bartek J, Alattar AA, Chen CC. Comparison of Frame-Based Versus Frameless Intracranial Stereotactic Biopsy: Systematic Review and Meta-Analysis. World Neurosurg. 2019;127:607–616.e4. doi:10.1016/j.wneu.2019.04.016
Enchev Y. Checklists in neurosurgery to decrease preventable medical errors: A review. Balkan Med J. 2015;32(4):337–346. doi:10.5152/balkanmedj.2015.15481
McConnell DJ, Fargen KM, Mocco J. Surgical checklists: A detailed review of their emergence, development, and relevance to neurosurgical practice. Surg Neurol Int. 2012;3(1). doi:10.4103/2152–7806.92163
Giordano M, Gallieni M, Zaed I, Samii A. Use of Frameless Stereotactic Navigation System Combined with Intraoperative Magnetic Resonance Imaging and 5-Aminolevulinic Acid. World Neurosurg. 2019;131:32–37. doi:10.1016/j.wneu.2019.07.171
B.V. M. StealthStation ® S7 ® Treatment Guidance System Manual. 2012;revision 1(9733782).
Zhang QJ, Wang WH, Wei XP, Yu YG. Safety and efficacy of frameless stereotactic brain biopsy techniques. Chinese Med Sci J. 2013;28(2):113–116. doi:10.1016/S1001–9294(13)60032–2
Widmann G, Schullian P, Ortler M, Bale R. Frameless stereotactic targeting devices: Technical features, targeting errors and clinical results. Int J Med Robot. 2012;8:1–16. doi:10.1002/rcs.441
Kesserwan MA, Shakil H, Lannon M, et al. Frame-based versus frameless stereotactic brain biopsies: A systematic review and meta-analysis. Surg Neurol Int. 2021;12(52):1–8. doi:10.25259/SNI_824_2020
Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJJ, Vincent AJPE. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir (Wien). 2008;150(1):23–29. doi:10.1007/s00701–007–1473-x
Livermore LJ, Ma R, Bojanic S, Pereira EAC. Yield and complications of frame-based and frameless stereotactic brain biopsy-The value of intra-operative histological analysis. Br J Neurosurg. 2014;28(5):637–644. doi:10.3109/02688697.2014.887657
Taweesomboonyat C, Tunthanathip T, Sae-Heng S, Oearsakul T. Diagnostic yield and complication of frameless stereotactic brain biopsy. J Neurosci Rural Pract. 2019;10(1):78–84. doi:10.4103/jnrp.jnrp_166_18
Jain D, Sharma MC, Sarkar C, Deb P, Gupta D, Mahapatra AK. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. Brain Tumor Pathol. 2006;23(2):71–75. doi:10.1007/s10014–006–0204-y